Furthermore, we found that the proportion of Tpex cells and Tex‐term cells of CD45.1+CD8+ T cells was significantly lower in tumor tissues treated with anti‐PD‐1 mAbs or CX4945 compared to controls, whereas the combination treatment group had a higher expression of IFN‐γ (Figure S8A, Supporting Information). This evidence concerns the gene CD8A and neoplasm.